Enhancing the Delivery of Erythropoietin and Its Variants into the Ischemic Brain
The hematopoietic growth factor erythropoietin (EPO) and its neuroprotective, but not hematopoietic, variants asialoEPO, carbamylated EPO (CEPO), and low sialic acid EPO (Neuro-EPO) are attractive candidates for stroke treatment. Due to their large molecular weight, these proteins enter the brain on...
| Published in: | The Scientific World Journal |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Online Access: | http://dx.doi.org/10.1100/tsw.2009.104 |